ROBIN ANDERSON: Open Payments
NPI 1780012245 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$70,452 in 201 payments from 23 companies in 2025. Trend: 2023 $108,797 · 2024 $82,302 · 2025 $70,452
Speaker / faculty: $46,900Travel & lodging: $12,877Honoraria: $5,600Food & beverage: $5,075
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 99 | $68,350 |
| ABBVIE INC. | 28 | $543 |
| Amgen Inc. | 8 | $259 |
| Novo Nordisk Inc | 12 | $196 |
| PFIZER INC. | 9 | $181 |
| RECORDATI_RARE_DISEASES_INC. | 10 | $169 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $141 |
| Aimmune Therapeutics, Inc. | 3 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $83 |
| Bausch Health US, LLC | 4 | $65 |
Products named: Korlym, REPATHA, UBRELVY, NURTEC ODT, ISTURISA, CREON, XIFAXAN, ZENPEP.
Industry payments across IN — which companies pay providers there.
